ArticleHeliyon2024
Mapping roof coverings of asbestos-cement, the first step to control the technical condition/threat and establish priorities for replacement in developing countries.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Index-based FT-IR assessment of chrysotile detectability and environmental durability in asbestos cement materials.Scientific reports · 2026Article
- Asbestos Poverty as a New Paradigm for Multidimensional Urban Sustainability.Journal of urban health : bulletin of the New York Academy of Medicine · 2026Article
- Mapping Asbestos Vulnerability in Indonesia Using Earthquake Vulnerability.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2025Article
- Mosses in Urban Environments as Passive Biofilters and Organisms Impacted by Asbestos-Contaminated Habitats.International journal of environmental research and public health · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper presents a systematic and data-driven approach to prioritize interventions in urban areas with asbestos cement (AC) roofs, addressing the urgent need to mitigate asbestos-related risks. The objective is to propose a comprehensive methodology that considers multiple criteria at the neighborhood level, allowing for a nuanced assessment of intervention priorities. The methodology involves the normalization of various parameters, including population density, facility density, and the area covered by asbestos-cement roofs. In addition, an innovative aspect is introduced by incorporating weathering status identification data, represented as an index, validated in previous research, further enriching the evaluation process. The integration of these diverse factors allows for a holistic understanding of the risk landscape associated with AC roofs in urban settings. The cornerstone of the proposed approach is the development of a Priority Intervention Index (PII) at the neighborhood level. This index serves to standardize the assessment of intervention priorities, enabling a fair and transparent comparison across different regions. To enhance practical application, the PII is discretized into three categories, low, mid and high intervention priority. The results obtained are robust, replicable in other scenarios, and practical for decision-makers. The new methodology provides a structured and quantifiable approach to identify and prioritize areas for asbestos-related interventions based on well-defined criteria at the neighborhood level. The resulting prioritization strategy offers urban planners and local officials a clear and evidence-based tool to allocate resources efficiently and effectively manage the inherent risks associated with AC roofs in urban environments. The paper will describe how the prioritization can be applied "at the neighborhood level" by urban planners and local officials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.